Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 2 5Phase NA 3Phase 2/3 2Phase 1 2Phase EARLY_PHASE1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Gastrointestinal 1

Conditions

Polyps 1Neoplasms 1Colorectal Neoplasms 1Adenomatous Polyps 1Adenoma 1

Interventions

Cisplatin 54Cyclophosphamide 42Fluorouracil 41Oxaliplatin 36Capecitabine 35Docetaxel 34Gemcitabine 32Drug Therapy 32Radiotherapy 31Paclitaxel 25Dexamethasone 23Carboplatin 23Leucovorin 21Etoposide 17Doxorubicin 17Cytarabine 17apatinib 16Methotrexate 16Magnetic Resonance Spectroscopy 14Radiation 13Epirubicin 13Busulfan 13Bevacizumab 13Surgical Procedures, Operative 12Neoadjuvant Therapy 12Letrozole 12Decitabine 12Saline Solution 11Irinotecan 11venetoclax 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × OTHER × Calcium Carbonate × Clear all
NCT01052051 2019-07-24

CAPS

Creighton University

Phase 2/3 Completed
2,303 enrolled
Tumor-Agnostic

Neoplasms

NCT00153816 2017-03-15

Vitamin D/Calcium Polyp Prevention Study

Dartmouth-Hitchcock Medical Center

Phase 2/3 Completed
2,813 enrolled 15 charts
Gastrointestinal

Adenoma, Polyps, Colorectal Neoplasms, Adenomatous Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡